首页|肺力咳合剂联合盐酸氨溴索和阿奇霉素治疗老年支原体肺炎患者的效果

肺力咳合剂联合盐酸氨溴索和阿奇霉素治疗老年支原体肺炎患者的效果

扫码查看
目的:观察肺力咳合剂联合盐酸氨溴索和阿奇霉素治疗老年支原体肺炎患者的效果.方法:选取 2020 年 1 月至 2022 年1 月该院收治的 80 例老年支原体肺炎患者进行前瞻性研究,按照随机数字表法分为观察组与对照组各 40 例.对照组采用盐酸氨溴索联合阿奇霉素治疗,观察组在对照组基础上加用肺力咳合剂治疗,比较两组治疗总有效率,发热、咳嗽、咳痰、肺部干湿啰音等临床症状消失时间和住院时间,血清炎性因子[细胞间黏附分子-1(ICAM-1)、白细胞介素-1β(IL-1β)和C反应蛋白(CRP)]水平,肺功能指标[最大呼气峰流速(PEF)、第 1 秒用力呼气容积(FEV1)/用力肺活量(FVC)]水平和不良反应发生率.结果:观察组治疗总有效率为 95.00%,明显高于对照组的 72.50%,差异有统计学意义(P<0.05);观察组发热、咳嗽、咳痰、肺部干湿啰音等临床症状消失时间和住院时间均短于对照组,差异有统计学意义(P<0.05);治疗后,两组血清ICAM-1、IL-1β和CRP水平低于治疗前,且观察组低于对照组,差异均有统计学意义(P<0.05);治疗后,两组FEV1/FVC、PEF水平高于治疗前,且观察组高于对照组,差异均有统计学意义(P<0.05);两组不良反应发生率比较,差异无统计学意义(P>0.05).结论:肺力咳合剂联合盐酸氨溴索和阿奇霉素治疗老年支原体肺炎患者可提高治疗总有效率和肺功能指标水平,缩短发热、咳嗽、咳痰、肺部干湿啰音消失时间和住院时间,降低炎性因子水平,效果优于单纯盐酸氨溴索和阿奇霉素治疗.
Effects of Feilike mixture combined with Ambroxol hydrochloride and Azithromycin in treatment of elderly patients with mycoplasma pneumonia
Objective:To observe effects of Feilike mixture combined with Ambroxol hydrochloride and Azithromycin in treatment of elderly patients with mycoplasma pneumonia.Methods:A prospective study was conducted on 80 elderly patients with mycoplasma pneumonia admitted to this hospital from January 2020 to January 2022.They were divided into observation group and control group according to the random number table method,40 cases in each group.The control group was treated with Ambroxol hydrochloride combined with Azithromycin,while the observation group was treated with Feilike mixture on the basis of those of the control group.The total effective rate of treatment,the disappearance time of clinical symptoms such as fever,cough,expectoration,lung dry and wet rales and the hospitalization time,the levels of serum inflammatory factors[intercellular adhesion molecule-1(ICAM-1),interleukin-1β(IL-1β)and C-reactive protein(CRP)],the lung function indexes[peak expiratory flow(PEF),forced expiratory volume in one second(FEV1)/forced vital capacity(FVC)],and the incidence of adverse reactions were compared between the two groups.Results:The total effective rate of the observation group was 95.00% ,which was significantly higher than 72.50% of the control group,and the difference was statistically significant(P<0.05).The disappearance time of clinical symptoms such as fever,cough,expectoration,lung dry and wet rales and the hospitalization time in the observation group were shorter than those in the control group,and the differences were statistically significant(P<0.05).After the treatment,the levels of serum ICAM-1,IL-1β and CRP in the two groups were lower than those before the treatment,those in the observation group were lower than those in the control group,and the differences were statistically significant(P<0.05).After the treatment,the levels of FEV1/FVC and PEF in the two groups were higher than those before the treatment,those in the observation group were higher than those in the control group,and the differences were statistically significant(P<0.05).However,there was no significant difference in the incidence of adverse reactions between the two groups(P>0.05).Conclusions:Feilike mixture combined with Ambroxol hydrochloride and Azithromycin in the treatment of the elderly patients with mycoplasma pneumonia can improve the total effective rate of treatment and the levels of lung function indexes,shorten the disappearance time of fever,cough,expectoration,lung dry and wet rales and the hospitalization time,and reduce the levels of inflammatory factors.Moreover,it is superior to single Ambroxol hydrochloride and Azithromycin treatment.

ElderlyMycoplasma pneumoniaAmbroxol hydrochlorideFeilike mixtureLung functionInflammatory factor

王长福、羊文彩、周玉茹

展开 >

上蔡仁爱医院内科,河南 驻马店 463800

老年 支原体肺炎 盐酸氨溴索 肺力咳合剂 肺功能 炎性因子

2024

中国民康医学
中国社会工作协会

中国民康医学

影响因子:0.649
ISSN:1672-0369
年,卷(期):2024.36(4)
  • 8